JACC: CardioOncology - IntroductionCardio-oncology is a growing field that encompasses managing cardiotoxic effects of oncologic therapies and preventing cardiovascular (CV) disease in patients with cancer and survivors....
Articles from: JACC: CardioOncology
JACC: CardioOncology - IntroductionAs the most populous country in the world, in the year 2020, there will be approximately 4.5 million new cases of cancer in China...
-
"As the most populous country in the world, in the year 2020, there will be approximately 4.5 million new cases of #cancer in China. Cancer and #CVD are the 2 most common causes of mortality in China." Learn more from #JACCCardioOnc: https://t.co/9DCMdSFRJB #CardioOnc
Amyloidosis and 30-Day Outcomes Among Patients With Heart Failure: A Nationwide Readmissions Database Study
posted 4 weeks
Mashup Score: 3
JACC: CardioOncology - Abstract Background The burden of amyloidosis among hospitalized patients is increasing over time. However, amyloidosis remains an underdiagnosed cause of heart failure (HF) hospitalization...
-
Amyloidosis and 30-Day Outcomes Among Patients With Heart Failure: A Nationwide Readmissions Database Study. Authors investigated the prevalence and prognostic implications of amyloidosis among patients hospitalized with HF #WorldCancerDay @JACCJournals https://t.co/73jY7Kda84 https://t.co/73jY7Kda84
Hypertension in Cancer Patients and Survivors: Epidemiology, Diagnosis, and Management
posted 4 weeks
Mashup Score: 3
JACC: CardioOncology - Abstract Cancer patients and survivors of cancer have a greater burden of cardiovascular disease compared with the general population. Much of the elevated cardiovascular...
-
Dr. Ky also referenced a #JACCCardioOnc state-of-the-art review on #hypertension in #cancer patients. Learn more: https://t.co/WRN12yNOHR #CardioOnc https://t.co/WRN12yNOHR
Patterns of Anticoagulation Use in Patients With Cancer With Atrial Fibrillation and/or Atrial Flutter:
posted 3 days
Mashup Score: 3
JACC: CardioOncology - Abstract Background Atrial fibrillation (AF) is a common cardiovascular complication affecting patients with cancer, but management strategies are not well established. Objectives The purpose...
-
ICYMI: Cancer patients with #AFib and elevated CHA2DS2-VASc score may not be receiving recommended #cvCoag for #stroke prophylaxis. Opportunity to improve care. Learn more: https://t.co/wT8sNpXLPi #JACCCardioOnc @Dr_Mike_Fradley @mealomar @kharodmd @sara_khodor7 https://t.co/wT8sNpXLPi
Cardio-Oncology in Brazil: The Dimensions of a New Era in the Care of Patients
posted 4 weeks
Mashup Score: 2
JACC: CardioOncology - IntroductionOccupying nearly one-half of South America’s landmass, Brazil is the largest country of the continent. The country has a diverse range of tropical and...
-
In a recent #JACCCardioOnc Leadership Page, Drs. @clarissamathias and Ludhmila Abrahão Hajjar describe #CardioOnc in Brazil🇧🇷. Learn more: https://t.co/II3tK3Omjm #CardioOnc
Increase in Blood Pressure Associated With Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor:
posted 4 weeks
Mashup Score: 2
JACC: CardioOncology - Abstract Objectives This study quantified the change in blood pressure (BP) during antivascular endothelial growth factor (VEGF) tyrosine kinase inhibitor (TKI) therapy, compared BPs...
-
Check out a recent paper #JACCCardioOnc Editor-in-Chief Dr. Bonnie Ky referenced on #bloodpressure elevations in the #CardioOnc chat: https://t.co/e4biQf99Ox #TKI https://t.co/e4biQf99Ox
JACC: CardioOncology - Abstract Background Despite known clinical risk factors, predicting anthracycline cardiotoxicity remains challenging. Objectives This study sought to develop a clinical and genetic risk prediction...
-
Machine Learning Identifies Clinical and Genetic Factors Associated With Anthracycline Cardiotoxicity in Pediatric #Cancer Survivors https://t.co/A2uH62raIh #WorldCancerDay @JACCJournals https://t.co/A2uH62raIh
JACC: CardioOncology - Abstract Background Doxorubicin (DOX) induces cardiotoxicity in part by activation of matrix metalloproteinases (MMPs). Sacubitril/valsartan (Sac/Val) exerts additive cardioprotective actions over...
-
Dual Angiotensin Receptor-Neprilysin Inhibition With Sacubitril/Valsartan Attenuates Systolic Dysfunction in Experimental Doxorubicin-Induced Cardiotoxicity. #WorldCancerDay @JACCJournals https://t.co/vWVTcETRtM https://t.co/vWVTcETRtM
Cardiac Biomarkers During Cancer Therapy: Practical Applications for Cardio-Oncology
posted 4 weeks
Mashup Score: 1
JACC: CardioOncology - IntroductionCombined modality approaches to cancer treatment have dramatically improved clinical outcomes. At the same time, there has been increased attention to acute, chronic, and...
-
Cardiac Biomarkers During Cancer Therapy: Practical Applications for Cardio-Oncology https://t.co/YZawZYeuCp #WorldCancerDay @JACCJournals https://t.co/YZawZYeuCp
Want to learn more about the implementation of #CardioOnc training for cardiology fellows? Check out this recent @JACCJournals article from Drs. @EimanJahangir, @drbrowncares, @datsunian et al. https://t.co/1e19oitDHy #ACCFIT